To take or not to take: Decision-making about antiretroviral treatment in people living with HIV/AIDS

AIDS Patient Care and STDs

Volumn 20, Issue 5, 2006, Pages 335-349

  Kremer, Heidemarie ^a   Ironson, Gail ^a   Schneiderman, Neil ^a   Hautzinger, Martin ^b  

^a Department of Biology   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; CD4 LYMPHOCYTE COUNT; DIARRHEA; FATIGUE; FEMALE; HEALTH INSURANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYALGIA; NAUSEA; NIGHT SWEAT; PATIENT ATTITUDE; PATIENT DECISION MAKING; QUALITY OF LIFE; RELIGION; SEMI STRUCTURED INTERVIEW; STOMACH PAIN; TREATMENT REFUSAL; UNPLEASANT DREAM; VIRUS LOAD; VIRUS RESISTANCE;

ADULT; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; COMPLEMENTARY THERAPIES; CROSS-SECTIONAL STUDIES; DECISION MAKING; FEMALE; FLORIDA; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HIV INFECTIONS; HUMANS; INSURANCE, HEALTH; LONGITUDINAL STUDIES; MALE; PATIENT COMPLIANCE; QUESTIONNAIRES; SPOUSES; SURVIVORS; VIRAL LOAD;

EID: 33744498084     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2006.20.335     Document Type: Article

References (48)

1. Cooper V, Buick D, Horne R, et al. Perceptions of HAART among gay men who declined a treatment offer: Preliminary results from an interview-based study. AIDS Care 2002;14:319-328.
2. Ferguson TF, Stewart KE, Funkhouser E, Tolson J, Westfall AO, Saag MS. Patient-perceived barriers to antiretroviral adherence: Associations with race. AIDS Care 2002;14:607-617.
3. Gellaitry G, Cooper V, Davis C, Fisher M, Date HL, Home R. Patients' perception of information about HAART: Impact on treatment decisions. AIDS Care 2005;17:367-376.
4. Gold RS, Hinchy J, Batrouney CG. The reasoning behind decisions not to take up antiretroviral therapy in australians infected with HIV. Int J STD AIDS 2000;11:361-370.
5. Hirsch MS, Sterritt C. Conference report, early vs late initiation of antiretroviral therapy for HIV infection: A scientific roundtable meeting. September 24-26, 2003. Atlanta, GA: Medscape HIV/AIDS. 9. www.medscape.com/ viewarticle/463372 (Last accessed July 7, 2005).
6. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav 2004;8:141-150.
7. Kremer H, Bader A, O'Cleirigh C, Bierhoff HW, Brockmeyer NH. The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership? Eur J Med Res 2004;9:61-70.
8. Laws MB, Wilson IB, Bowser DM, Kerr SE. Taking antiretroviral therapy for HIV infection: Learning from patients' stories. J Gen Intern Med 2000;15:848-858.
9. McGuire S. Making the decision to start therapy on the level. BETA 2004;16:20-26.
10. Russell CK, Bunting SM, Graney M, Hartig MT, Kisner P, Brown B. Factors that influence the medication decision making of persons with HIV/AIDS: A taxonomic exploration. J Assoc Nurses AIDS Care 2003;14:46-60.
11. Phillips AN, Lepri AC, Lampe F, Johnson M, Sabin CA. When should antiretroviral therapy be started for HIV infection? interpreting the evidence from observational studies. AIDS 2003;17:1863-1869.
12. Wood E, Hogg RS, Harrigan PR, Montaner JS. When to initiate antiretroviral therapy in HIV-1-infected adults: A review for clinicians and patients. Lancet Infect Dis 2005;5:407-414.
13. Bogart LM, Kelly JA, Catz SL, Sosman JM. Impact of medical and nonmedical factors on physician decision making for HIV/AIDS antiretroviral treatment. J Acquir Immune Defic Syndr 2000;23:396-404.
14. Department of Health. The Expert Patient: A New Approach to Chronic Disease. Management for the 21st Century. London: Department of Health, 2001.
15. Kremer H. Compliance in der HIV-Therapie unter dem Aspekt der Selbstbestimmung. [Compliance with HIV-therapy under the aspect of patient's autonomy] [Master's thesis]. Bochum, Germany: Department of Psychology, Ruhr University Bochum, 2001.
16. Ironson G, Baibin E, Solomon G, et al. Relative preservation of natural killer cell cytotoxicity and number in healthy AIDS patients with low CD4 cell counts. AIDS 2001;15:2065-2073.
17. Ironson G, Solomon GF, Balbin EG, et al. The ironson-woods Spirituality/Religiousness index is associated with long survival, health behaviors, less distress, and low cortisol in people with HIV/AIDS. Ann Behav Med 2002;24:34-48.
18. Ironson G, Balbin E, Stuetzle R, et al. Dispositional optimism and the mechanisms by which it predicts slower disease progression in HIV: Proactive behavior, avoidant coping, and depression. Int J Behav Med 2005;12:86-97.
19. Ironson G, O'Cleirigh C, Fletcher MA, et al. Psychosocial factors predict CD4 and viral load change in men and women with HIV in the era of HAART. Psychosom Med 2005;67:1013-1026.
20. Department of Health and Human Services (DHHS) (US). Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents, www.aidsinfo. nih.gov/guidelines (Last accessed July 7, 2005).
21. AIDS Clinical Trials Group (ACTG). ACTG adherence follow-up questionnaire. 2001. www.caps.ucsf.edu/ projects/2098.4188.pdf (Last accessed July 7, 2005).
22. Mayring P. Qualitative Inhaltsanalyse. Grundlagen Und Techniken. [Qualitative Content Analysis. Basics and Techniques], 7th ed. Weinheim, Germany: Deutscher Studien Verlag, 2000.
23. Mayring P. Qualitative content analysis. Forum: Qualitative Social Research. (Last accessed July 7, 2005). www.qualitative-research.net/fqs-texte/ 2-00/ 2-00mayring-e.htm
24. Hays WL. Statistics, 3rd ed. New York, NY: Dyden Press, 1981.
25. Bakeman R, Gottmann JM. Observing Interaction. An Introduction to Sequential Analysis. Cambridge, UK: University Press, 1986.
26. Hooper H, Burwitz L, Hodkinson P. Exploring the benefits of a broader approach to qualitative research in sport psychology. A tale of two, or three, james. Forum: Qualitative Social Research. 2003;4. www.qualitative-research.net/ fqs-texte/1-03/1-03 hooperetal-e.htm (Last accessed July 7, 2005).
27. Wendler MC. Triangulation using a meta-matrix. J Adv Nurs 2001;35:521-525.
28. Gallant JE. Editorial comment: Strategies for success-A return to "hit early"? AIDS Read 2004;14:662-663.
29. Mauskopf J, Kitahata M, Kauf T, Richter A, Tolson J. HIV antiretroviral treatment: Early versus later. J Acquir Immune Defic Syndr 2005;39:562-569.
30. Zinkernagel C, Ledergerber B, Battegay M, et al. Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV cohort study. AIDS 1999;13:1587-1589.
31. Stone VE, Clarke J, Lovell J, et al. HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. J Gen Intern Med 1998;13:586-593.
32. Golin CE, Liu H, Hays RD, et al. A prospective study of predictors of adherence to combination antiretroviral medication. J Gen Intern Med 2002;17:756-765.
33. Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133:21-30.
34. Wenger N, Gifford A, Liu H, et al. Patient characteristics and attitudes associated with antiretroviral (AR) adherence [Abstract 98]. 6th Conference on Retroviruses and Opportunistic Infections, Chicago, IL: 1999.
35. Golin CE, Smith SR, Reif S. Adherence counseling practices of generalist and specialist physicians caring for people living with HIV/AIDS in north Carolina. J Gen Intern Med 2004;19:16-27.
36. Wagner GJ, Ryan GW. Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDs 2004;18:385-393.
37. Cassileth B. The Alternative Medicine Handbook: The Complete Reference Guide to Alternative and Complementary Therapies, 1st ed. New York: W.W. Norton & Company, 1998.
38. Antoni MH, Cruess DG, Klimas N, et al. Stress management and immune system reconstitution in symptomatic HIV-infected gay men over time: Effects on transitional naive T cells (CD4(+)CD45RA(+) CD29(+)). Am J Psychiatry 2002;159:143-145.
39. Chesney MA, Chambers DB, Taylor JM, Johnson LM, Folkman S. Coping effectiveness training for men living with HIV: Results from a randomized clinical trial testing a group-based intervention. Psychosom Med 2003;65:1038-1046.
40. Ironson G, Antoni MH, Schneiderman N, et al. Stress management and psychosocial predictors of disease course in HIV-1 infection. In: Goodkin K, Visser AP, eds. Psychoneuroimmunology, Stress, Mental Disorders and Health. Washington, D.C.: American Psychiatric Press, 2000:317-356.
41. Gallant JE, Block DS. Adherence to antiretroviral regimens in HIV-infected patients: Results of a survey among physicians and patients. J Int Assoc Physicians AIDS Care 1998;4:32-35.
42. Stone VE, Jordan J, Tolson J, Miller R, Pilon T. Perspectives on adherence and simplicity for HIV-infected patients on antiretroviral therapy: Self-report of the relative importance of multiple attributes of highly active antiretroviral therapy (HAART) regimens in predicting adherence. J Acquir Immune Defic Syndr 2004;36:808-816.
43. Crane JR, Perlman S, Meredith KL, et al. Women with HIV: Conflicts and synergy of prayer within the realm of medical care. AIDS Educ Prev 2000;12:532-543.
44. Koenig HG. MSJAMA: Religion, spirituality, and medicine: Application to clinical practice. JAMA 2000;284:1708.
45. Southwell H, Valdez H, Lederman M, Gripshover B. Use of alternative therapies among HIV-infected patients at an urban tertiary care center. J Acquir Immune Defic Syndr 2002;31:119-120..
46. Colebunders R, Dreezen C, Florence E, Pelgrom Y, Schrooten W, Eurosupport Study Group. The use of complementary and alternative medicine by persons with HIV infection in Europe. Int J STD AIDS 2003;14:672-674.
47. Albarracin D, Wyer RS Jr. The cognitive impact of past behavior: Influences on beliefs, attitudes, and future behavioral decisions. J Pers Soc Psychol 2000;79:5-22.
48. DiMatteo MR. Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Med Care 2004;42:200-209.